Clinical Study Results
There were 1.2% of participants who died during this study. This was 22 out of 1,843 participants.
The doctors did not think that any of these deaths were related to the study medicines.
How many participants had adverse reactions?
There were 4.4% of participants who had adverse reactions during this study. This was 81 out of 1,843 participants.
What adverse reactions did the participants have?
The most common adverse reaction was an infection of the mouth caused by yeast.

Adverse reactions during this study:
- Infection of the mouth caused by yeast: 1.0% (6), 0.8% (5), 0.8% (5), 0.9% (16)
- Difficulty breathing: 1.1% (7), 0.5% (3), 0.7% (4), 0.8% (14)

How has this study helped participants and researchers?
This study helped researchers learn how different treatments of budesonide and formoterol fumarate affect the lung function of patients with COPD.
Researchers look at the results of many studies to decide which treatments work best and are safest. This summary shows only the main results from this 1 study. Other studies may provide new information or different results.
Further clinical studies in COPD with treatments of budesonide and formoterol fumarate together are not planned.